1. Tacrine-(hydroxybenzoyl-pyridone) hybrids as potential multifunctional anti-Alzheimer's agents: AChE inhibition, antioxidant activity and metal chelating capacity
    Karam Chand et al, 2016, Journal of Inorganic Biochemistry CrossRef
  2. Huperzine A ameliorates neurological deficits after spontaneous subarachnoid hemorrhage through endothelial cell pyroptosis inhibition
    Qiang Hu et al, 2024, Acta Biochimica et Biophysica Sinica CrossRef
  3. Huperzine A from Huperzia serrata: a review of its sources, chemistry, pharmacology and toxicology
    Ana Ferreira et al, 2016, Phytochemistry Reviews CrossRef
  4. Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research
    U. Damar et al, 2016, Expert Review of Neurotherapeutics CrossRef
  5. The effects of acetylcholinesterase inhibitors on the heart in acute myocardial infarction and heart failure: From cells to patient reports
    Thawatchai Khuanjing et al, 2020, Acta Physiologica CrossRef
  6. Study on biological activity of tissues from bivalve mollusks
    E. P. Karaulova et al, 2018, Izvestiya TINRO CrossRef
  7. Pyridostigmine improves cardiac function and rhythmicity through RyR2 stabilization and inhibition of STIM1‐mediated calcium entry in heart failure
    Stephen Baine et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
  8. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease
    Wen-Yu Wu et al, 2017, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
  9. Administration of Huperzine A microspheres ameliorates myocardial ischemic injury via α7nAChR-dependent JAK2/STAT3 signaling pathway
    Ce Zhang et al, 2023, European Journal of Pharmacology CrossRef
  10. Phthalamide derivatives as ACE/AChE/BuChE inhibitors against cardiac hypertrophy: an in silico, in vitro, and in vivo modeling approach
    Erik Andrade-Jorge et al, 2021, Medicinal Chemistry Research CrossRef
  11. Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction
    Bahira Shahim et al, 2024, European Heart Journal - Cardiovascular Pharmacotherapy CrossRef
  12. Candesartan ameliorates acute myocardial infarction in rats through inducible nitric oxide synthase, nuclear factor-κB, monocyte chemoattractant protein-1, activator protein-1 and restoration of heat shock protein 72
    XUEFENG LIN et al, 2015, Molecular Medicine Reports CrossRef
  13. Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
    Cecilia Villegas et al, 2022, IUBMB Life CrossRef
  14. Effectiveness of anthocyanin-containing foods and nutraceuticals in mitigating oxidative stress, inflammation, and cardiovascular health-related biomarkers: a systematic review of animal and human interventions
    Nima Mohammadi et al, 2024, Food & Function CrossRef
  15. Blueberry Anthocyanins-Enriched Extracts Attenuate Cyclophosphamide-Induced Cardiac Injury
    Yunen Liu et al, 2015, PLOS ONE CrossRef
  16. Cardioprotective Effects of Tetrahydropalmatine on Acute Myocardial Infarction in Rats
    Bing-Jing Han et al, 2022, The American Journal of Chinese Medicine CrossRef
  17. Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer’s disease
    Ugur Damar et al, 2017, Medical Hypotheses CrossRef
  18. Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation
    Renren Bai et al, 2021, European Journal of Medicinal Chemistry CrossRef
  19. Endophytic Fungal Community of Huperzia serrata: Diversity and Relevance to the Production of Huperzine A by the Plant Host
    Lingli Cui et al, 2021, Molecules CrossRef